Black pepper oil
Black pepper oil has antioxidant and anti-inflammatory properties and can be used in research on arthritis, respiratory diseases, and other ailments.
For research use only. We do not sell to patients.
- CAS No.: 8006-82-4
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
-
Help & FAQs
-
HY-W133894
Cedar oilEssential Oil -
HY-107803
Geranium oilEstrogen Receptor Partial Agonist -
HY-N14116
Garlic oilAnti-inflammatory/Antioxidant/Anticancer agent -
HY-N18788
Orange sweet oilNatural Extract -
HY-N18798
Ginger oilNatural Extract -
HY-N18827
Citronella oilNatural Extract -
HY-N18825
Lemongrass oilNatural Extract -
HY-N18828
Basil oilNatural Extract -
HY-N18812
Coriander oilNatural Extract -
HY-N18814
Carrot seed oilNatural Extract -
HY-174434
Cumin oilCosolvent -
HY-N18808
Matricaria oilNatural Extract
Biological Activity
Description
Chemical Information
Protocols
-
Collagen-Induced Arthritis
Collagen-induced arthritis (CIA) is an autoimmune murine model of rheumatoid arthritis in which immunization with type II collagen (CII) emulsified in an adjuvant induces a T cell- and autoantibody-driven inflammatory arthritis characterized by synovial hyperplasia, immune cell infiltration, and joint destruction. The model typically relies on genetically susceptible mouse strains (e. g. , DBA/1) and reproduces key features of human rheumatoid arthritis, including anti-collagen immune responses and progressive joint inflammation. Disease onset generally occurs within ~3-4 weeks after immunization, depending on antigen/adjuvant combinations and protocol variation. The immunopathology is driven by adaptive immune activation against CII, leading to systemic and local joint inflammation mediated by pro-inflammatory cytokines and effector immune cells, making CIA a standard preclinical platform for evaluating immunomodulatory and anti-arthritic interventions.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Black pepper oil Related Classifications
HY-N18796 Related Classifications
Powered by Bioz